Hi Itsa, this is an article that can provide insight and...

Hi Itsa, this is an article that can provide insight and perspective and some understanding about the world of research and development, anchored specifically to ATL-1102 and also CD49d.
What goes on in the background , the obstacles and challenges that arise and the realities of creating novel biotech.
For example a product may have efficacy in viva but not so in vitro, and why this may occur, so as to overcome it.
This is also an example of CD49d and how it can be related to inflammations in a great many ways.
This article is a reposititory of understanding if read in that perspective, but it has to be read whilst submerged in the article.
This is a snapshot representing discovery, the ups and downs.
This article is for those that are interested in what goes on that we dont see, and the complexities , challenges , hard work and creative supposition that gets converted to positive results.
This article can feed curiosity and provide insight. If a person has no interest in this area then the article is probably of no interest, and boring.
This is an article that we can read, if we like this type of reading, while we wait for outcomes and events in the future, because waiting is required.

On a side note, MS is something i think will be reactivated after Tox and funding monies are ample.